Protein palmitoylation in cancer: molecular functions and therapeutic potential

B Zhou, Q Hao, Y Liang, E Kong - Molecular oncology, 2023 - Wiley Online Library
Protein S‐palmitoylation (hereinafter referred to as protein palmitoylation) is a reversible
lipid posttranslational modification catalyzed by the zinc finger DHHC‐type containing …

Role of natural and synthetic compounds in modulating NRF2/KEAP1 signaling pathway in prostate cancer

G Tossetta, S Fantone, D Marzioni, R Mazzucchelli - Cancers, 2023 - mdpi.com
Simple Summary Several studies showed that oxidative stress is involved in cancer
occurrence, development, progression chemoresistance and radio resistance. The nuclear …

Nano Proteolysis Targeting Chimeras (PROTACs) with Anti‐Hook Effect for Tumor Therapy

NY Zhang, DY Hou, XJ Hu, JX Liang… - Angewandte …, 2023 - Wiley Online Library
Proteolysis targeting chimera (PROTAC) is an emerging pharmacological modality with
innovated post‐translational protein degradation capabilities. However, off‐target induced …

[HTML][HTML] DDX5 and DDX17—multifaceted proteins in the regulation of tumorigenesis and tumor progression

K Xu, S Sun, M Yan, J Cui, Y Yang, W Li… - Frontiers in …, 2022 - frontiersin.org
DEAD-box (DDX) 5 and DDX17, which belong to the DEAD-box RNA helicase family, are
nuclear and cytoplasmic shuttle proteins. These proteins are expressed in most tissues and …

Cancer Stemness/Epithelial–Mesenchymal Transition Axis Influences Metastasis and Castration Resistance in Prostate Cancer: Potential Therapeutic Target

EA Castellón, S Indo, HR Contreras - International Journal of Molecular …, 2022 - mdpi.com
Prostate cancer (PCa) is a leading cause of cancer death in men, worldwide. Mortality is
highly related to metastasis and hormone resistance, but the molecular underlying …

Neurokinin-1 receptor drives PKCɑ-AURKA/N-Myc signaling to facilitate the neuroendocrine progression of prostate cancer

XW Zhang, JY Li, L Li, WQ Hu, Y Tao, WY Gao… - Cell Death & …, 2023 - nature.com
The widespread application of antiandrogen therapies has aroused a significant increase in
the incidence of NEPC, a lethal form of the disease lacking efficient clinical treatments. Here …

Endocrine disruptors and prostate cancer

M Corti, S Lorenzetti, A Ubaldi, R Zilli… - International Journal of …, 2022 - mdpi.com
The role of endocrine disruptors (EDs) in the human prostate gland is an overlooked issue
even though the prostate is essential for male fertility. From experimental models, it is known …

Estrogen receptors-mediated apoptosis in hormone-dependent cancers

A Chimento, A De Luca, P Avena, F De Amicis… - International journal of …, 2022 - mdpi.com
It is known that estrogen stimulates growth and inhibits apoptosis through estrogen receptor
(ER)-mediated mechanisms in many cancer cell types. Interestingly, there is strong evidence …

The extracellular matrix stiffening: a trigger of prostate cancer progression and castration resistance?

C Luthold, T Hallal, DP Labbé, F Bordeleau - Cancers, 2022 - mdpi.com
Simple Summary Prostate cancer is a malignancy that affects a high number of men all over
the world. When indolent, prostate cancer can remain silent for years without needing …

The endoplasmic reticulum stress response in prostate cancer

CM de la Calle, K Shee, H Yang, PE Lonergan… - Nature Reviews …, 2022 - nature.com
In order to proliferate in unfavourable conditions, cancer cells can take advantage of the
naturally occurring endoplasmic reticulum-associated unfolded protein response (UPR) via …